Bacteriophage Therapy

Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.


Bacteriophage Therapy: Developments and Directions.


Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.


Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.


Bacteriophage therapy to combat bacterial infections in poultry.


Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria.


Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy.


Bacteriophage therapy.


Phage Therapy in the Postantibiotic Era.


Veterinary use of bacteriophage therapy in intensively-reared livestock.


Phage Therapy: What Have We Learned?


Propionibacterium (Cutibacterium) acnes Bacteriophage Therapy in Acne: Current Evidence and Future Perspectives.


Biological challenges of phage therapy and proposed solutions: a literature review.


A review of bacteriophage therapy for pathogenic bacteria inactivation in the soil environment.


A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.


Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.


Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.


Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.


Phage therapy for respiratory infections.


A Wake-Up Call: We Need Phage Therapy Now.


Biotechnological applications of bacteriophages: State of the art.


Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.


An exegesis of bacteriophage therapy: An emerging player in the fight against anti-microbial resistance.


Filamentous bacteriophage: A prospective platform for targeting drugs in phage-mediated cancer therapy.


Bacteriophage Interactions with Marine Pathogenic Vibrios: Implications for Phage Therapy.


Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.


From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture.


Pharmacological limitations of phage therapy.


Phage cocktails and the future of phage therapy.


Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System.


Phage display screening of therapeutic peptide for cancer targeting and therapy.


Complex interactions between the microbiome and cancer immune therapy.


History of Envenoming Therapy and Current Perspectives.


Phage display-derived human antibodies in clinical development and therapy.


Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.


Bacteriophage therapy--cooked goose or phoenix rising?


Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.


Call for a dedicated European legal framework for bacteriophage therapy.


Towards Inhaled Phage Therapy in Western Europe.


Phage-Based Applications in Synthetic Biology.


Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?


Bacteriophage-derived vectors for targeted cancer gene therapy.


Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth.


Contribution of the Immune Response to Phage Therapy.


New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections.


Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy.


Combating Cholera.


Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.


Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell.


scFv antibody: principles and clinical application.


Bacteriophages and Their Immunological Applications against Infectious Threats.


Rebuilding the Gut Microbiota Ecosystem.


Development of therapeutic antibodies for the treatment of diseases.


Campylobacter bacteriophages and bacteriophage therapy.


Pathogenic factors of Pseudomonas aeruginosa - the role of biofilm in pathogenicity and as a target for phage therapy.


Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.


Phage Therapy with a Focus on the Human Microbiota.


Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.


The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections.


Emerging therapies against infections with Pseudomonas aeruginosa.


A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.


Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.


Bacteriophage Production Models: An Overview.


Virome and bacteriome: two sides of the same coin.


The disparate effects of bacteriophages on antibiotic-resistant bacteria.


Methicillin-Resistant Staphylococcus aureus in Hospitals: Latest Trends and Treatments Based on Bacteriophages.

COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis.


Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.


Tumor-targeting peptides from combinatorial libraries.


Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?


Antibody phage display: technique and applications.


Current State of Compassionate Phage Therapy.


Phage Therapy in the Era of Synthetic Biology.


Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii.


Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infections.


Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.


Phage therapy in allergic disorders?


Exploring the whole standard operating procedure for phage therapy in clinical practice.


Engineered Bacteriophages for Practical Applications.


Tumor penetrating peptides for improved drug delivery.


Recent biocontrol measures for fish bacterial diseases, in particular to probiotics, bio-encapsulated vaccines, and phage therapy.


Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses.


Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects.


The Magistral Phage.


The Perfect Bacteriophage for Therapeutic Applications-A Quick Guide.


Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients.


Phage Therapy in Gastrointestinal Diseases.


Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.


Bacteriophage interactions with mammalian tissue: Therapeutic applications.


Human monoclonal antibodies as candidate therapeutics against emerging viruses.


Ameliorating the antimicrobial resistance crisis: phage therapy.


Phage Therapy in Prostatitis: Recent Prospects.


Current trends in targeted therapy for drug-resistant infections.


Bacteriophage interactions with phagocytes and their potential significance in experimental therapy.


Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.


HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration.


Phage therapy: eco-physiological pharmacology.


Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory.


How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.


Understanding and Exploiting Phage-Host Interactions.


Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.


Bacteriophage translocation.


Animal Models to Translate Phage Therapy to Human Medicine.


Phage therapy--constraints and possibilities.


Bacteriophage Procurement for Therapeutic Purposes.


Secondary Bacterial Infections in Patients With Viral Pneumonia.


Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors.


The Rationale for Using Bacteriophage to Treat and Prevent Periprosthetic Joint Infections.




Human Virome and Disease: High-Throughput Sequencing for Virus Discovery, Identification of Phage-Bacteria Dysbiosis and Development of Therapeutic Approaches with Emphasis on the Human Gut.


Enhancing phage therapy through synthetic biology and genome engineering.


Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease.


Bacteriophage Treatment: Critical Evaluation of Its Application on World Health Organization Priority Pathogens.


Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations.


Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies.


Pharmacological Interventions for Bacterial Prostatitis.


Phage therapy of pulmonary infections.


Growing Trend of Fighting Infections in Aquaculture Environment-Opportunities and Challenges of Phage Therapy.


The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review.


Bacteriophages as Alternatives to Antibiotics in Clinical Care.


Non-traditional Antibacterial Therapeutic Options and Challenges.


The use of bacteriophages to biocontrol oral biofilms.


Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.


The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review.


An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review.


Bacteriophage biocontrol of foodborne pathogens.


Microbiota and Phage Therapy: Future Challenges in Medicine.


In vitro-engineered non-antibody protein therapeutics.


Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases.


The Diversity of Bacterial Lifestyles Hampers Bacteriophage Tenacity.


RNA-Based Vaccines in Cancer Immunotherapy.


The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole.


Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.


Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria.


Viruses of protozoan parasites and viral therapy: Is the time now right?


Efficacy of phikm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection.


Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy.


Re-establishing a place for phage therapy in western medicine.


Phage therapy against Enterococcus faecalis in dental root canals.


Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases.


Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases.


Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.


T4 bacteriophage as a phage display platform.


Insights into Bacteriophage Application in Controlling Vibrio Species.


Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy.


Criteria for Selecting Suitable Infectious Diseases for Phage Therapy.


Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli.


Genetically Engineered Phages: a Review of Advances over the Last Decade.


Emerging drug development technologies targeting ubiquitination for cancer therapeutics.


The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.


Molecular Basis of Bacterial Host Interactions by Gram-Positive Targeting Bacteriophages.


Phage Therapy in Poland - a Centennial Journey to the First Ethically Approved Treatment Facility in Europe.


Bacteriophage penetration in vertebrates.


Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products.


Phages in Therapy and Prophylaxis of American Foulbrood - Recent Implications From Practical Applications.


Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities.


Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process.


Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview.


Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii.


Application of Phage-Displayed Peptides in Tumor Imaging Diagnosis and Targeting Therapy.


Frontiers in Molecular Evolutionary Medicine.


Bacteriophage remediation of bacterial pathogens in aquaculture: a review of the technology.

Modeling tailed bacteriophage adsorption: Insight into mechanisms.


Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.


Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.


Robust Approaches for the Production of Active Ingredient and Drug Product for Human Phage Therapy.


Phage-Based Artificial Niche: The Recent Progress and Future Opportunities in Stem Cell Therapy.


Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.


Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections.


Sepsis, Phages, and COVID-19.




Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics.


Bacteriophage lysins as effective antibacterials.


Bacteriophage orphan DNA methyltransferases: insights from their bacterial origin, function, and occurrence.


Bacteriophages of Helicobacter pylori.


A novel delivery platform based on Bacteriophage MS2 virus-like particles.


Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia.


Phages for Biofilm Removal.


The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems.


Phages in Anaerobic Systems.


In Vitro Characteristics of Phages to Guide 'Real Life' Phage Therapy Suitability.


Phages of life - the path to pharma.


Bacteriophages in Dentistry-State of the Art and Perspectives.


Bacteriophage and their lysins for elimination of infectious bacteria.


Bacteriophage biocontrol in animals and meat products.


Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.


Viral Related Tools against SARS-CoV-2.


Proteus mirabilis Biofilm: Development and Therapeutic Strategies.


Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.


The role of mesothelin in tumor progression and targeted therapy.


Opportunities and challenges for TCR mimic antibodies in cancer therapy.


Bacteriophages in Natural and Artificial Environments.


Alternatives to overcoming bacterial resistances: State-of-the-art.


The factors affecting effectiveness of treatment in phages therapy.


Encapsulation and Delivery of Therapeutic Phages.


A Review of Topical Phage Therapy for Chronically Infected Wounds and Preparations for a Randomized Adaptive Clinical Trial Evaluating Topical Phage Therapy in Chronically Infected Diabetic Foot Ulcers.


Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.